Clinical Evidence on EksoGT
Clinical Studies: Ongoing and Completed
Since 2012, Ekso Bionics, Inc. has sponsored or supported clinical research using the Ekso 1.1 and EksoGT exoskeletons. The vast majority of completed and ongoing studies are investigator-initiated. As of mid-2018, nearly 2000 participants have been or are involved in more than 50 completed studies and 30 ongoing studies. Because the first Ekso device was designed for those with spinal cord injury (SCI), most early research was conducted with SCI participants. With newer hardware and software accommodating more impairments, studies in patients with stroke and other neurological diagnoses have been quickly increasing. Half of the research is conducted within the U.S with the remainder within the EMEA. As expected, many of the feasibility studies have led to larger studies (single-arm or comparative) where the investment of time and resources is considerable. Ekso Bionics, Inc. remains committed to demonstrating clinical benefit through research.
Publications and Presentations
Past research activity using the Ekso devices has culminated in over 40 conference presentations and publications, and featured in five review articles. Of the published articles, 18 describe results of Ekso use in individuals with spinal cord injury, two report on research related to Ekso in stroke survivors, and one pertains to multiple sclerosis. The graph below shows how the areas of research are now more diversified.